Craig K. Esser

886 total citations
12 papers, 600 citations indexed

About

Craig K. Esser is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Craig K. Esser has authored 12 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Craig K. Esser's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Receptor Mechanisms and Signaling (3 papers). Craig K. Esser is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Receptor Mechanisms and Signaling (3 papers). Craig K. Esser collaborates with scholars based in United States. Craig K. Esser's co-authors include William K. Hagmann, James P. Springer, Alice I. Marcy, Jeffrey D. Hermes, Joseph W. Becker, Patricia M. Cameron, Laura L. Rokosz, Jonathan J. Burbaum, Paula M.D. Fitzgerald and Bruce A. Johnson and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Craig K. Esser

12 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig K. Esser United States	11	321	318	289	149	97	12	600
Philippe Cuniasse France	11	325 1.0×	370 1.2×	401 1.4×	168 1.1×	75 0.8×	11	634
Laura L. Rokosz United States	14	379 1.2×	178 0.6×	227 0.8×	167 1.1×	60 0.6×	26	660
Christopher D. Floyd United Kingdom	8	623 1.9×	481 1.5×	523 1.8×	477 3.2×	99 1.0×	11	1.2k
Ashutosh Pal United States	16	525 1.6×	121 0.4×	340 1.2×	130 0.9×	69 0.7×	44	983
Nadiya Sydorenko United States	11	398 1.2×	158 0.5×	217 0.8×	411 2.8×	31 0.3×	17	893
Moshe Weitzberg United States	15	242 0.8×	125 0.4×	62 0.2×	266 1.8×	58 0.6×	28	638
Danae M. Sharp Australia	7	491 1.5×	144 0.5×	363 1.3×	97 0.7×	60 0.6×	10	865
Anastasios Makaritis Greece	7	269 0.8×	226 0.7×	272 0.9×	206 1.4×	39 0.4×	8	496
Robert B. Garland United States	15	463 1.4×	74 0.2×	159 0.6×	479 3.2×	97 1.0×	26	925
David T. Parker United States	10	235 0.7×	236 0.7×	222 0.8×	178 1.2×	45 0.5×	14	515

Countries citing papers authored by Craig K. Esser

Since Specialization

Citations

This map shows the geographic impact of Craig K. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig K. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig K. Esser more than expected).

Fields of papers citing papers by Craig K. Esser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig K. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig K. Esser. The network helps show where Craig K. Esser may publish in the future.

Co-authorship network of co-authors of Craig K. Esser

This figure shows the co-authorship network connecting the top 25 collaborators of Craig K. Esser. A scholar is included among the top collaborators of Craig K. Esser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig K. Esser. Craig K. Esser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2010). GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 20(15). 4472–4474. 10 indexed citations

Imbriglio, Jason E., Daniel A. DiRocco, Subharekha Raghavan, et al.. (2010). The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties. Bioorganic & Medicinal Chemistry Letters. 21(9). 2721–2724. 13 indexed citations

Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2009). GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 19(8). 2121–2124. 13 indexed citations

Lewis, Chad A., Michele Kubryk, Jaume Balsells, et al.. (2006). Remote Desymmetrization at Near-Nanometer Group Separation Catalyzed by a Miniaturized Enzyme Mimic. Journal of the American Chemical Society. 128(51). 16454–16455. 74 indexed citations

Chang, Jiang, et al.. (1999). Synthesis of di- and trisubstituted guanidines on multivalent soluble supports. Tetrahedron Letters. 40(24). 4477–4480. 7 indexed citations

Esser, Craig K., et al.. (1997). Solid-phase synthesis of a N-carboxyalkyl tripeptide combinatorial library. Bioorganic & Medicinal Chemistry Letters. 7(20). 2639–2644. 12 indexed citations

Becker, Joseph W., Alice I. Marcy, Laura L. Rokosz, et al.. (1995). Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme. Protein Science. 4(10). 1966–1976. 223 indexed citations

Esser, Craig K., Ihor E. Kopka, Philippe L. Durette, et al.. (1995). Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides containing extended alkyl residues At P1'. Bioorganic & Medicinal Chemistry Letters. 5(6). 539–542. 11 indexed citations

Sahoo, Soumya P., Charles G. Caldwell, Kevin T. Chapman, et al.. (1995). Inhibition of matrix metalloproteinases by N-carboxyalkyl dipeptides: Enhanced potency and selectivity with substituted P1′ homophenylalanines. Bioorganic & Medicinal Chemistry Letters. 5(20). 2441–2446. 20 indexed citations

10.

Gooley, Paul R., Juliette O’Connell, Alice I. Marcy, et al.. (1994). The NMR structure of the inhibited catalytic domain of human stromelysin–1. Nature Structural & Molecular Biology. 1(2). 111–118. 122 indexed citations

11.

Gooley, Paul R., Bruce A. Johnson, Alice I. Marcy, et al.. (1993). Secondary structure and zinc ligation of human recombinant short-form stromelysin by multidimensional heteronuclear NMR. Biochemistry. 32(48). 13098–13108. 43 indexed citations

12.

Chapman, Kevin T., Ihor E. Kopka, Philippe L. Durette, et al.. (1993). Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides. Journal of Medicinal Chemistry. 36(26). 4293–4301. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact